202 related articles for article (PubMed ID: 11932471)
1. Neuroblastoma screening at one year of age.
Schilling FH; Spix C; Berthold F; Erttmann R; Fehse N; Hero B; Klein G; Sander J; Schwarz K; Treuner J; Zorn U; Michaelis J
N Engl J Med; 2002 Apr; 346(14):1047-53. PubMed ID: 11932471
[TBL] [Abstract][Full Text] [Related]
2. Screening of infants and mortality due to neuroblastoma.
Woods WG; Gao RN; Shuster JJ; Robison LL; Bernstein M; Weitzman S; Bunin G; Levy I; Brossard J; Dougherty G; Tuchman M; Lemieux B
N Engl J Med; 2002 Apr; 346(14):1041-6. PubMed ID: 11932470
[TBL] [Abstract][Full Text] [Related]
3. Lead-time and overdiagnosis estimation in neuroblastoma screening.
Spix C; Michaelis J; Berthold F; Erttmann R; Sander J; Schilling FH
Stat Med; 2003 Sep; 22(18):2877-92. PubMed ID: 12953286
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of screening for neuroblastoma at 6 months of age: a retrospective population-based cohort study.
Hiyama E; Iehara T; Sugimoto T; Fukuzawa M; Hayashi Y; Sasaki F; Sugiyama M; Kondo S; Yoneda A; Yamaoka H; Tajiri T; Akazawa K; Ohtaki M
Lancet; 2008 Apr; 371(9619):1173-80. PubMed ID: 18395578
[TBL] [Abstract][Full Text] [Related]
5. Is the mass screening for neuroblastoma ineffective?
Nishi M; Hanai J; Fujita K; Ichimiya H; Tanaka T; Hatae Y; Takeda T
J Exp Clin Cancer Res; 2003 Dec; 22(4):673-6. PubMed ID: 15053313
[TBL] [Abstract][Full Text] [Related]
6. Which cases are found and missed by neuroblastoma screening at 1 year? Results from the 1992 to 1995 study in three Federal States of Germany.
Berthold F; Baillot A; Hero B; Schurr P; Nerenz A; Hunneman DH; Sander J
J Clin Oncol; 1999 Apr; 17(4):1200. PubMed ID: 10561179
[TBL] [Abstract][Full Text] [Related]
7. Mass screening of neuroblastoma in Sapporo City, Japan.
Nishi M; Miyake H; Takeda T; Kikuchi Y; Hanai J; Yonemori H; Takasugi N
Am J Pediatr Hematol Oncol; 1992 Nov; 14(4):327-31. PubMed ID: 1456398
[TBL] [Abstract][Full Text] [Related]
8. A population-based study of the usefulness of screening for neuroblastoma.
Woods WG; Tuchman M; Robison LL; Bernstein M; Leclerc JM; Brisson LC; Brossard J; Hill G; Shuster J; Luepker R; Byrne T; Weitzman S; Bunin G; Lemieux B
Lancet; 1996 Dec 21-28; 348(9043):1682-7. PubMed ID: 8973429
[TBL] [Abstract][Full Text] [Related]
9. Children may not benefit from neuroblastoma screening at 1 year of age. Updated results of the population based controlled trial in Germany.
Schilling FH; Spix C; Berthold F; Erttmann R; Sander J; Treuner J; Michaelis J
Cancer Lett; 2003 Jul; 197(1-2):19-28. PubMed ID: 12880955
[TBL] [Abstract][Full Text] [Related]
10. [The "Lower Saxony/Northern Rhine-Westphalia" Neuroblastoma Screening Project: on the need for epidemiologic comparison].
Berthold F; Sander J; Baillot A; Hunneman DH; Michaelis J
Klin Padiatr; 1992; 204(4):288-92. PubMed ID: 1518267
[TBL] [Abstract][Full Text] [Related]
11. Incidence of neuroblastoma after a screening program.
Barrette S; Bernstein ML; Robison LL; Samson Y; Brossard J; Weitzman S; Woods WG
J Clin Oncol; 2007 Nov; 25(31):4929-32. PubMed ID: 17971590
[TBL] [Abstract][Full Text] [Related]
12. Contribution of HPLC mass screening for neuroblastoma to a decrease in mortality.
Nishi M; Takeda T; Hatae Y; Hanai J; Fujita K; Ichimiya H; Tanaka T
J Exp Clin Cancer Res; 2002 Mar; 21(1):73-8. PubMed ID: 12071533
[TBL] [Abstract][Full Text] [Related]
13. Folic acid food fortification is associated with a decline in neuroblastoma.
French AE; Grant R; Weitzman S; Ray JG; Vermeulen MJ; Sung L; Greenberg M; Koren G
Clin Pharmacol Ther; 2003 Sep; 74(3):288-94. PubMed ID: 12966372
[TBL] [Abstract][Full Text] [Related]
14. [Improved survival in children with neuroblastoma].
Schrøder H; Wacher J; Larsson H; Rosthøj S; Rechnitzer C; Petersen BL; Carlsen NL
Ugeskr Laeger; 2010 Oct; 172(40):2761-5. PubMed ID: 20926047
[TBL] [Abstract][Full Text] [Related]
15. [Neuroblastoma in children: clinical and biological aspects. An experience of screening in France].
Mathieu P; Favrot M; Frappaz D; Chauvin F; Greffe J; Montegue A; Lacroix C; David L; Brunat-Mentigny M; Philip T
Ann Biol Clin (Paris); 1993; 51(7-8):665-88. PubMed ID: 8166384
[TBL] [Abstract][Full Text] [Related]
16. Screening for neuroblastoma: a review of the evidence.
Chamberlain J
J Med Screen; 1994 Jul; 1(3):169-75. PubMed ID: 8790511
[TBL] [Abstract][Full Text] [Related]
17. Premature birth and later insulin resistance.
Hofman PL; Regan F; Jackson WE; Jefferies C; Knight DB; Robinson EM; Cutfield WS
N Engl J Med; 2004 Nov; 351(21):2179-86. PubMed ID: 15548778
[TBL] [Abstract][Full Text] [Related]
18. Treatment complications in children diagnosed with neuroblastoma during a screening program.
Barrette S; Bernstein ML; Leclerc JM; Champagne MA; Samson Y; Brossard J; Woods WG
J Clin Oncol; 2006 Apr; 24(10):1542-5. PubMed ID: 16575005
[TBL] [Abstract][Full Text] [Related]
19. [Present status of neuroblastoma mass screening in Japan. Neuroblastoma-Committee of the Japanese Childhood Cancer Society].
Sawada T; Nagahara N; Ohi R; Yamamoto K; Okabe I; Hanawa Y; Hashizume K; Matsui I; Ohkawa H; Tunoda A
Gan To Kagaku Ryoho; 1990 Dec; 17(12):2319-26. PubMed ID: 2260868
[TBL] [Abstract][Full Text] [Related]
20. Past and future of neuroblastoma screening in Japan.
Sawada T
Am J Pediatr Hematol Oncol; 1992 Nov; 14(4):320-6. PubMed ID: 1456397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]